Evidence map›Paper›PMID 29302461›Full record

ArticleCardiovascular diagnosis and therapy2017

Warfarin anticoagulation in acute type A aortic dissection survivors (WATAS).

Yskert von Kodolitsch, Oliver Wilson, Helke Schüler, Axel Larena-Avellaneda, Tilo Kölbel, Sabine Wipper, Fiona Rohlffs, Christian Behrendt, E Sebastian Debus, Jens Brickwedel and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Cardiovascular diagnosis and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

Yskert von KodolitschCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Oliver WilsonCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Helke SchülerCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Axel Larena-AvellanedaCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Tilo KölbelCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Sabine WipperCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Fiona RohlffsCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Christian BehrendtCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
E Sebastian DebusCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Jens BrickwedelCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Evaldas GirdauskasCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Christian DetterCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Alexander M BernhardtCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Jürgen BergerDepartment of Medical Biometry and Epidemiology, the University Hospital Eppendorf, Hamburg, Germany.
Stefan BlankenbergCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Hermann ReichenspurnerCentre of Cardiology and Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Tamer GhazyDepartment of Cardiac Surgery, University Heart Center Dresden, Dresden, Germany.
Klaus MatschkeDepartment of Cardiac Surgery, University Heart Center Dresden, Dresden, Germany.
Ralf-Thorsten HoffmannUniversity Center for Vascular Medicine and Institute for Diagnostic Radiology, Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Norbert WeissUniversity Center for Vascular Medicine and Division of Angiology, Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Adrian MahlmannUniversity Center for Vascular Medicine and Division of Angiology, Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Universität Hamburg · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly survivors of acute type A aortic dissection (AAAD) remain at risk for late death and late aortic events. However, the frequency and long-term effects of warfarin anticoagulation on long-term outcome in post-surgical AAAD survivors have not been elucidated.

methodsTwo tertiary care centers performed a retrospective observational cohort study of warfarin anticoagulation in AAAD in 243 persons with early survival of surgical repair (WATAS). Serial postoperative tomographic imaging was available in 106 persons.

resultsA total of 88 postoperative AAAD survivors (36%) were on long-term warfarin anticoagulation. The indication for anticoagulation was a mechanical aortic prosthesis in 46 (52%), atrial fibrillation in 33 (38%), stroke in 7 (8%), and pulmonary embolism in 1 (1%). The indication for anticoagulation remained unclear in 1 person (1%). Survival and aortic event free survival were 98.3±0.01 and 98.7±0.01 at 1 year, and 76.4±0.03 and 91.8±0.02 at 5 years, respectively, with no differences irrespective of warfarin anticoagulation. Multivariate Cox regression analysis established higher age (P<0.001), and operation extending into the descending aorta (P=0.030) as independent predictors of late death. Follow-up without tomographic imaging independently predicted increased long-term mortality (P<0.001) and lower rates of documented aortic events (P=0.003). Kaplan-Meyer analysis showed a relationship of aortic diameter growth ≥0.5 cm per year with late death (P=0.041) and with late aortic events (P<0.001). However, rapid aortic growth did not relate to warfarin anticoagulation.

conclusionsWarfarin anticoagulation is frequent in postsurgical AAAD and it is administered for vital indications. Warfarin anticoagulation does not relate to late mortality or to late aortic events. Rapid aortic growth predicts late mortality and late aortic events, but warfarin anticoagulation is not associated with aortic growth. Follow-up tomographic imaging is mandatory for long-term survival after surgical repair of AAAD.

Indexed as

anticoagulationAortadissectionmortalitywarfarin

Identifiers

PMID29302461
PMCPMC5752825
OpenAlexW2764255706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.